vs
AMERICAN SHARED HOSPITAL SERVICES（AMS）与Research Solutions, Inc.（RSSS）财务数据对比。点击上方公司名可切换其他公司
Research Solutions, Inc.的季度营收约是AMERICAN SHARED HOSPITAL SERVICES的1.5倍（$11.8M vs $7.7M），Research Solutions, Inc.净利率更高（4.6% vs -8.2%，领先12.8%），Research Solutions, Inc.同比增速更快（-1.0% vs -14.8%），Research Solutions, Inc.自由现金流更多（$1.4M vs $-2.7M），过去两年AMERICAN SHARED HOSPITAL SERVICES的营收复合增速更高（21.7% vs -1.3%）
美国共享医院服务公司为医疗机构提供放射治疗、立体定向放射外科及诊断成像设备的整体外包解决方案，免除医院高昂的前期资本投入，主要业务覆盖北美，同时服务拉美及部分亚太地区的公立、私立医院客户。
雅各布斯解决方案是一家总部位于美国达拉斯的国际技术专业服务企业，面向全球各类客户（包括企业、机构及政府部门）提供工程、技术、专业、建筑相关服务，以及科研与专项咨询服务，常年位居《工程新闻纪录》顶级设计企业榜单榜首。
AMS vs RSSS — 直观对比
营收规模更大
RSSS
是对方的1.5倍
$7.7M
营收增速更快
RSSS
高出13.8%
-14.8%
净利率更高
RSSS
高出12.8%
-8.2%
自由现金流更多
RSSS
多$4.1M
$-2.7M
两年增速更快
AMS
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $7.7M | $11.8M |
| 净利润 | $-631.0K | $546.9K |
| 毛利率 | 11.7% | 52.4% |
| 营业利润率 | -18.1% | 6.3% |
| 净利率 | -8.2% | 4.6% |
| 营收同比 | -14.8% | -1.0% |
| 净利润同比 | 52.5% | 127.6% |
| 每股收益（稀释后） | $-0.09 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMSRSSS
| Q4 25 | $7.7M | $11.8M | ||
| Q3 25 | $7.2M | $12.3M | ||
| Q2 25 | $7.1M | $12.4M | ||
| Q1 25 | $6.1M | $12.7M | ||
| Q4 24 | $9.1M | $11.9M | ||
| Q3 24 | $7.0M | $12.0M | ||
| Q2 24 | $7.1M | $12.1M | ||
| Q1 24 | $5.2M | $12.1M |
净利润AMSRSSS
| Q4 25 | $-631.0K | $546.9K | ||
| Q3 25 | $-17.0K | $749.4K | ||
| Q2 25 | $-280.0K | $2.4M | ||
| Q1 25 | $-625.0K | $216.5K | ||
| Q4 24 | $-1.3M | $-2.0M | ||
| Q3 24 | $-207.0K | $669.0K | ||
| Q2 24 | $3.6M | $-2.8M | ||
| Q1 24 | $119.0K | $76.3K |
毛利率AMSRSSS
| Q4 25 | 11.7% | 52.4% | ||
| Q3 25 | 22.1% | 50.6% | ||
| Q2 25 | 23.1% | 51.0% | ||
| Q1 25 | 15.4% | 49.5% | ||
| Q4 24 | 35.3% | 48.9% | ||
| Q3 24 | 19.6% | 47.9% | ||
| Q2 24 | 35.0% | 46.5% | ||
| Q1 24 | 41.1% | 45.2% |
营业利润率AMSRSSS
| Q4 25 | -18.1% | 6.3% | ||
| Q3 25 | -4.8% | 7.8% | ||
| Q2 25 | -7.7% | 9.7% | ||
| Q1 25 | -21.3% | 4.4% | ||
| Q4 24 | -20.2% | 0.8% | ||
| Q3 24 | -12.7% | 5.4% | ||
| Q2 24 | -0.0% | 5.5% | ||
| Q1 24 | -1.6% | 0.7% |
净利率AMSRSSS
| Q4 25 | -8.2% | 4.6% | ||
| Q3 25 | -0.2% | 6.1% | ||
| Q2 25 | -4.0% | 19.0% | ||
| Q1 25 | -10.2% | 1.7% | ||
| Q4 24 | -14.6% | -16.6% | ||
| Q3 24 | -3.0% | 5.6% | ||
| Q2 24 | 51.0% | -23.3% | ||
| Q1 24 | 2.3% | 0.6% |
每股收益（稀释后）AMSRSSS
| Q4 25 | $-0.09 | $0.02 | ||
| Q3 25 | $0.00 | $0.02 | ||
| Q2 25 | $-0.04 | $0.08 | ||
| Q1 25 | $-0.10 | $0.01 | ||
| Q4 24 | $-0.21 | $-0.07 | ||
| Q3 24 | $-0.03 | $0.02 | ||
| Q2 24 | $0.55 | $-0.09 | ||
| Q1 24 | $0.02 | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | $12.3M |
| 总债务越低越好 | $17.4M | — |
| 股东权益账面价值 | $24.0M | $17.2M |
| 总资产 | $55.5M | $44.2M |
| 负债/权益比越低杠杆越低 | 0.72× | — |
8季度趋势，按日历期对齐
现金及短期投资AMSRSSS
| Q4 25 | $3.5M | $12.3M | ||
| Q3 25 | $5.1M | $12.0M | ||
| Q2 25 | $11.1M | $12.2M | ||
| Q1 25 | $11.2M | $9.9M | ||
| Q4 24 | $11.0M | $7.7M | ||
| Q3 24 | $13.8M | $6.9M | ||
| Q2 24 | $14.2M | $6.1M | ||
| Q1 24 | $12.8M | $4.2M |
总债务AMSRSSS
| Q4 25 | $17.4M | — | ||
| Q3 25 | $18.2M | — | ||
| Q2 25 | $19.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | $20.4M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $15.1M | — | ||
| Q1 24 | $15.6M | — |
股东权益AMSRSSS
| Q4 25 | $24.0M | $17.2M | ||
| Q3 25 | $24.6M | $15.6M | ||
| Q2 25 | $24.5M | $13.9M | ||
| Q1 25 | $24.6M | $11.2M | ||
| Q4 24 | $25.2M | $11.1M | ||
| Q3 24 | $26.4M | $12.8M | ||
| Q2 24 | $26.5M | $11.7M | ||
| Q1 24 | $22.8M | $14.1M |
总资产AMSRSSS
| Q4 25 | $55.5M | $44.2M | ||
| Q3 25 | $59.6M | $45.5M | ||
| Q2 25 | $63.5M | $46.1M | ||
| Q1 25 | $63.3M | $45.2M | ||
| Q4 24 | $60.2M | $42.8M | ||
| Q3 24 | $63.3M | $41.4M | ||
| Q2 24 | $60.8M | $41.9M | ||
| Q1 24 | $50.1M | $40.8M |
负债/权益比AMSRSSS
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 0.81× | — | ||
| Q4 24 | 0.81× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.57× | — | ||
| Q1 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-704.0K | $1.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.7M | $1.4M |
| 自由现金流率自由现金流/营收 | -34.8% | 11.7% |
| 资本支出强度资本支出/营收 | 25.7% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 2.53× |
| 过去12个月自由现金流最近4个季度 | $-8.5M | — |
8季度趋势，按日历期对齐
经营现金流AMSRSSS
| Q4 25 | $-704.0K | $1.4M | ||
| Q3 25 | $1.7M | $1.1M | ||
| Q2 25 | $-372.0K | $2.3M | ||
| Q1 25 | $2.5M | $2.9M | ||
| Q4 24 | $274.0K | $1.0M | ||
| Q3 24 | $472.0K | $843.1K | ||
| Q2 24 | $1.3M | $2.0M | ||
| Q1 24 | $-1.9M | $2.0M |
自由现金流AMSRSSS
| Q4 25 | $-2.7M | $1.4M | ||
| Q3 25 | $-2.0M | $1.1M | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-1.5M | $2.9M | ||
| Q4 24 | $-4.4M | — | ||
| Q3 24 | $-407.0K | — | ||
| Q2 24 | $70.0K | $1.9M | ||
| Q1 24 | $-3.0M | $2.0M |
自由现金流率AMSRSSS
| Q4 25 | -34.8% | 11.7% | ||
| Q3 25 | -28.3% | 8.8% | ||
| Q2 25 | -32.1% | — | ||
| Q1 25 | -24.7% | 22.8% | ||
| Q4 24 | -48.4% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 1.0% | 16.0% | ||
| Q1 24 | -58.4% | 16.6% |
资本支出强度AMSRSSS
| Q4 25 | 25.7% | 0.1% | ||
| Q3 25 | 51.6% | 0.1% | ||
| Q2 25 | 26.9% | — | ||
| Q1 25 | 65.7% | 0.0% | ||
| Q4 24 | 51.4% | — | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 17.2% | 0.1% | ||
| Q1 24 | 22.7% | 0.0% |
现金转化率AMSRSSS
| Q4 25 | — | 2.53× | ||
| Q3 25 | — | 1.48× | ||
| Q2 25 | — | 0.96× | ||
| Q1 25 | — | 13.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.26× | ||
| Q2 24 | 0.36× | — | ||
| Q1 24 | -15.67× | 26.43× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMS
| Direct Patient Services | $4.0M | 51% |
| Rental Income From Medical Services | $2.7M | 35% |
| Pbrt Services | $1.2M | 15% |
RSSS
| Transactions | $6.6M | 56% |
| Platforms | $5.2M | 44% |
